The company
CollPlant Biotechnologies Ltd. -
CLGN · Nasdaq
CLGN stood above a rising 150-day average in 0 of the last 52 weekly readings. It is 6.0% below that average now. Medical Devices: 27% of its 181 stocks in an uptrend (−9 points in four weeks); Health Care: 25% (−11 points in four weeks).
Statistics
- Rotation
- Not moving yet
- Weeks in an uptrend
- out for 52
- Industry in uptrend
- 27% -9 in 4 wk
- Insider buys, 12 months
- $0
- Insider sales, 12 months
- $0
- Officials’ trades on record
- 0
- Institutions holding
- 15 (-4)
In the rotation
Each square a week: lit when it closed above a rising 150-day average. 0 of 52 weeks.
Medical Devices: A minority of its stocks are in an uptrend and the share has fallen sharply over four weeks. Health Care: A minority of its stocks are in an uptrend and the share has fallen sharply over four weeks.
Money in and out
Open-market buys above the line and sales below, in dollars.
Congress and officials
No member of Congress or official has disclosed a trade in it.
Insiders
No open-market buy or sale by its insiders on record.
Lines filed since 2 January 2026, newest first; every insider’s older lines are on their own page.
Institutions
Quarter to 30 Jun 2026, against 31 Mar 2026; newest filing 31 Aug 2026.
| Manager | Shares | Change |
|---|---|---|
| PINNACLE ASSOCIATES LTDadded · filed 3 Aug 2026 | 731,663$255K | +181,434+33.0% |
| VILLERE ST DENIS J & CO LLCreduced · filed 7 Aug 2026 | 606,400$212K | -900−0.1% |
| BROWN ADVISORY INCreduced · filed 14 Aug 2026 | 104,731$37K | -14,000−11.8% |
| RENAISSANCE TECHNOLOGIES LLCadded · filed 13 Aug 2026 | 61,500$21K | +44,700+266.1% |
| Pathstone Holdings, LLCunchanged · filed 13 Aug 2026 | 57,000$20K | 00.0% |
| CITADEL ADVISORS LLCadded · filed 14 Aug 2026 | 53,700$19K | +21,535+67.0% |
| Legacy Wealth Managment, LLCunchanged · filed 13 Aug 2026 | 23,179$8,087 | 00.0% |
| WATERS PARKERSON & CO., LLCunchanged · filed 30 Jul 2026 | 13,250$4,623 | 00.0% |
| XTX Topco Ltdreduced · filed 14 Aug 2026 | 13,081$4,564 | -1,714−11.6% |
| UBS Group AGadded · filed 13 Aug 2026 | 1,035$361 | +940+989.5% |
News
No headline names it lately.
Everyone who traded it
Same industry
Government contracts
No federal award is tied to it.
From its SEC filings
Analyst forecasts
No analyst forecasts yet.